Nicotinamide N-Methyltransferase from Human, Recombinant

inquiry

Cat No.

NATE-1656

Description

Nicotinamide N-Methyltransferase (NNMT) methylates nicotinamide and other pyridine containing compounds. NNMT transfers a methyl group from S-adenosylmethionine (SAM) to nitrogen N1 of nicotinamide to produce 1-methylnicotinamide (MNA) and S-adenosylhomocysteine. MNA is a messenger molecule that increases neurite branching, serves as an anti-thrombotic, and has anti-inflammatory properties. The role of NNMT overexpression in cancers may be to alter epigenetic methylation patterns in two ways: by lowering the intracellular concentration of SAM, required by methyltransferase enzymes, and by depleting the available NAD+ by transforming nicotinamide to MNA. Sirtuins use NAD+ as a substrate to alter protein acetylation and ribosylation, including histone targets.

Abbr

NNMT, Recombinant (Human)

Source

recombinant N-terminal His- and SUMO-tagged protein expressed in E. coli

Species

Human

Form

Liquid

Enzyme Commission Number

E.C. 2.1.1.1

Molecular Weight

42.6 kDa

Purity

> 95% by SDS-PAGE

Stability

As supplied, 6 months from the QC date provided on the Certificate of Analysis, when stored properly

Storage

Store at -80°C

Synonyms

NNMT

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry